BOC Sciences Joins Forces With Innovators At PODD Conference 2025
From October 27-28, at the Westin Copley Place in Boston, BOC Sciences will be at Booth #114, not just as a vendor, but as a strategic partner and a catalyst for innovation. This brand is driven by the insight that the next great therapeutic is waiting for a great delivery system, and its role is to provide high-quality, specialized components and expertise to make it happen.
The BOC Sciences team will showcase its unique ability to synthesize and scale up essential drug delivery systems like lipid-based nanoparticles (LNPs) , liposomes, and micelles. This isn't about off-the-shelf products; it's about providing custom-formulated solutions that empower scientists to deliver mRNA, siRNA, or any other therapeutics that they specialize in.
The company will also highlight its core expertise and how it helps partners solve key challenges, with a spotlight on:
Bioconjugation: Precision conjugation with GalNAc, PEG, and cholesterol.
ADC Payloads : Complete support for toxin-linker synthesis and conjugation.
Tailored Carriers: Polymers and dendrimers for sustained and targeted release.
Nucleic Acid Delivery: One-stop mRNA/siRNA formulation and scale-up.
"At PODD, we see ourselves as an important partner in innovative science," a representative of BOC Sciences said. "Our offering of comprehensive drug delivery services, state-of-the-art bioconjugation technologies, and custom-formulated lipid nanoparticles is tailored to deliver the medicines of the future. We have come together to form strategic alliances that will accelerate the delivery of safer, better therapies to patients around the world."
Uniting for the future of drug delivery, BOC Sciences welcomes all visitors to meet its team at Booth #114 and discover new partnership opportunities. To ensure a focused conversation, attendees are encouraged to schedule a meeting with BOC Sciences ahead of time.
About BOC Sciences
BOC Sciences is a trusted supplier to the global life sciences community, delivering advanced chemicals, drug delivery systems, and comprehensive contract research services. It is committed to supporting its clients' missions to discover and develop life-saving and life-enhancing therapies, and its contributions have already helped enable numerous groundbreaking discoveries.
Alex Brown
BOC Sciences
email us here
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- New Cryptocurrency Mutuum Finance (MUTM) Raises $15.8M As Phase 6 Reaches 40%
- Bydfi Joins Korea Blockchain Week 2025 (KBW2025): Deepening Web3 Engagement
- Yield Basis Nears Mainnet Launch As Curve DAO Votes On Crvusd Proposal
- 0G Labs Launches Aristotle Mainnet With Largest Day-One Ecosystem For Decentralized AI
- Ethereum-Based Defi Crypto Mutuum Finance (MUTM) Raises Over $16 Million With More Than 720M Tokens Sold
- Fintech's Gender Gap In Focus: Drofa Comms' Women Leading The Way Joins Evolvh3r's She Connects At TOKEN2049
Comments
No comment